Disease causality

Last updated: November 01, 2022

Disease causality

Year 1

Year 1

Skin histology
Introduction to pharmacology
Skin anatomy and physiology
Wound healing
Introduction to biostatistics
Types of data
Vaccinations
Inflammation
Nuclear structure
Pharmacodynamics: Agonist, partial agonist and antagonist
DNA structure
Anemia: Clinical
Anatomy of the heart
Hypertension
Hypertension: Clinical
Myocardial infarction
Clinical trials
Mitosis and meiosis
Calcium channel blockers
Class III antiarrhythmics: Potassium channel blockers
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug absorption and distribution
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Cardiac muscle histology
Blood histology
Artery and vein histology
Arteriole, venule and capillary histology
Loop diuretics
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
Osmotic diuretics
Carbonic anhydrase inhibitors
Bone histology
Cartilage histology
Skeletal muscle histology
Central nervous system histology
Peripheral nervous system histology
Diabetes mellitus
Phenylketonuria (NORD)
Homocystinuria
Familial hypercholesterolemia
Fats and lipids
Cholesterol metabolism
Carbohydrates and sugars
Proteins
Extracellular matrix
Cytoskeleton and intracellular motility
Cell signaling pathways
Citric acid cycle
Electron transport chain and oxidative phosphorylation
Amino acid metabolism
Nitrogen and urea cycle
Nucleotide metabolism
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Type I and type II errors
Study designs
Ecologic study
Cross sectional study
Case-control study
Cohort study
Randomized control trial
Sensitivity and specificity
Positive and negative predictive value
Test precision and accuracy
Atrophy, aplasia, and hypoplasia
Hyperplasia and hypertrophy
Metaplasia and dysplasia
Bone tumors
Osteomyelitis
Osteoporosis
Osteomalacia and rickets
Septic arthritis
Cauda equina syndrome
The Oral Microbiota and Systemic Health
Bacterial structure and functions
Nasal cavity and larynx histology
Trachea and bronchi histology
Bronchioles and alveoli histology
Inheritance patterns
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
DNA mutations
Neuromuscular junction and motor unit
Pharmacodynamics: Drug-receptor interactions
Cholinergic receptors
Adrenergic receptors
Blood products and transfusion: Clinical
Muscle contraction
Sliding filament model of muscle contraction
Nervous system anatomy and physiology
Parasympathetic nervous system
Slow twitch and fast twitch muscle fibers
Enteric nervous system
Sympathetic nervous system
Resting membrane potential
Neuron action potential
Cell membrane
Selective permeability of the cell membrane
Blood groups and transfusions
Blood components
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Body fluid compartments
Movement of water between body compartments
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Carbon dioxide transport in blood
Bones of the vertebral column
Bones of the vertebral column
Joints of the vertebral column
Joints of the vertebral column
Joints of the wrist and hand
Bones of the upper limb
Fascia, vessels and nerves of the upper limb
Anatomy of the brachial plexus
Anatomy of the arm
Muscles of the forearm
Vessels and nerves of the forearm
Muscles of the hand
Anatomy of the sternoclavicular and acromioclavicular joints
Anatomy of the glenohumeral joint
Anatomy of the elbow joint
Anatomy of the radioulnar joints
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
Methods of regression analysis
Spearman's rank correlation coefficient
Mann-Whitney U test
Chi-squared test
Kaplan-Meier survival analysis
Incidence and prevalence
Relative and absolute risk
Odds ratio
Attributable risk (AR)
Direct standardization
Indirect standardization
Disease causality
Selection bias
Information bias
Confounding
Innate immune system
Complement system
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Upper respiratory tract infection
Heart failure
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Dyslipidemias: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Familial hypercholesterolemia
Deep vein thrombosis and pulmonary embolism: Pathology review
Chronic venous insufficiency
Ischemia
ECG cardiac infarction and ischemia
Angina pectoris
Aneurysms
Asthma: Clinical
Chronic bronchitis
Emphysema
Pulmonary hypertension
Idiopathic pulmonary fibrosis
Bronchiectasis
Lung cancer
Chronic obstructive pulmonary disease (COPD): Clinical
Respiratory distress syndrome: Pathology review
Myocardial infarction
Vasculitis
ACE inhibitors, ARBs and direct renin inhibitors
Adrenergic receptors
Adrenergic antagonists: Alpha blockers
Class II antiarrhythmics: Beta blockers
Adrenergic antagonists: Beta blockers
Antiplatelet medications
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Arteriole, venule and capillary histology
Microcirculation and Starling forces
Blood pressure, blood flow, and resistance
Resistance to blood flow
Lymphatic system anatomy and physiology
Laminar flow and Reynolds number
Compliance of blood vessels
Pressures in the cardiovascular system
Physiological changes during exercise
Measuring cardiac output (Fick principle)
Stroke volume, ejection fraction, and cardiac output
Frank-Starling relationship
Pressure-volume loops
Changes in pressure-volume loops
Cardiac work
Cardiac preload
Cardiac afterload
Law of Laplace
Baroreceptors
Renin-angiotensin-aldosterone system
Chemoreceptors
Cardiac conduction system
Action potentials in pacemaker cells
Action potentials in myocytes
Cardiac excitation-contraction coupling
Cardiac contractility
ECG basics
Cerebral circulation
Coronary circulation
Respiratory system anatomy and physiology
Reading a chest X-ray
Lung volumes and capacities
Anatomic and physiologic dead space
Alveolar surface tension and surfactant
Ventilation
Regulation of pulmonary blood flow
Zones of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Airflow, pressure, and resistance
Diffusion-limited and perfusion-limited gas exchange
Gas exchange in the lungs, blood and tissues
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Carpal tunnel syndrome

Transcript

Watch video only

One of the main goals of epidemiology is to identify causal relationships between outcomes - like death, diseases, or injuries - and exposures - like smoking cigarettes, eating junk food, or drinking alcohol.

For example, nowadays, it’s widely known that smoking cigarettes causes lung cancer, or in other words, that smoking cigarettes leads to the development of lung cancer in many people. But how did we figure this out?

In the mid- 1950’s, an epidemiologist named Sir Austin Bradford Hill came up with nine guidelines for determining whether or not two things are causally related, and these are called the Bradford Hill Criteria.

The first criterion refers to the strength of association, and says that two things are more likely to be causally related if the strength of association between them is large.

For example, for people who smoke, the relative risk of lung cancer is around 25, meaning people that smoke have 25 times the risk of developing lung cancer compared to people that don’t smoke.

On the flip side, the relative risk of breast cancer for people who smoke is only about 1.5, which is much lower than the relative risk of lung cancer.

So, smoking is much more likely to cause lung cancer than it is to cause breast cancer.

The second criterion states that causal relationships are dose- dependent, meaning a person who has higher amounts of exposure will also have a higher risk of developing the outcome.

For example, the relative risk of lung cancer for people who smoke 10 cigarettes per day might be 8, the relative risk of lung cancer for people who smoke 15 cigarettes per day might be 13, and the relative risk of lung cancer for people who smoke 20 cigarettes per day might be 22.

On the other hand, if a person decreases or stops their exposure, their risk of the outcome also decreases.

For example, in people who stop smoking, the risk of dying from lung cancer decreases by half.

In a causal relationship, the exposure has to precede or come before the outcome, and this is called temporality, which is the third criterion.

For example, typically people are more likely to develop lung cancer after they have smoked, so smoking comes before lung cancer.

Oftentimes, there is a lag- time or gap between the exposure and the outcome, and the timing of this gap also has to be consistently true.

For example, it usually takes 20 years for lung cancer to develop after a person begins to smoke, since the negative effects of smoking on the body build up over time.

So, we should see around a 20- year lag- time in all studies on smoking and lung cancer.

Generally, temporality is considered the strongest evidence for causal relationships.

The fourth criterion is that causal relationships must be biologically plausible, which means the relationship can be explained by biological mechanisms.

For example, cigarettes contain around 70 different chemicals that damage DNA, the main component of cells that controls how they grow and carry out different tasks.

Sometimes when DNA gets damaged, cells can start to grow uncontrollably, which can cause cancer to develop in the form of tumors.

Knowing the biological mechanism helps to eliminate possible confounders, or external factors that can distort the relationship between the exposure and the outcome.

The fifth criterion is that causal relationships should be coherent, meaning any new piece of biological evidence that’s discovered should fit into one step of the biological mechanism.

For example, new technology has allowed researchers to look at the specific genetic changes that happen when the DNA is damaged, which solidifies that step in the pathway from smoking to lung cancer.

Causal relationships are often supported by other, similar causal relationships, and the sixth criterion is referred to as analogy.

Specifically, a causal relationship between an exposure and an outcome is supported when there is existing evidence that a similar exposure causes a similar outcome.

For example, smoking causes genetic changes that can induce the growth of cancerous tumors in the larynx, pharynx, and mouth.

Knowing this, we can predict that smoking will have an analogous effect on the lungs.

The seventh criterion states that causal relationships need to be supported by results from randomized controlled trials or RCTs.

In randomized controlled trials, the researcher randomly assign two groups of people - one to be exposed and one to not be exposed.

Key Takeaways

Causality refers to a consequential relationship between two things. Disease causality is the relationship between a disease and its cause. A disease may have multiple causes, which can be categorized as either direct or indirect. Direct causes are those responsible for the initiation or aggravation of the disease process, while indirect causes predispose an individual to the development of a disease. Identifying the cause of a disease is essential to its treatment.